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and procedure. Rasuks: Women were older, more symptomatic, required
more urgent procedures and had more single vessel disease than men. EF
was similar. At baseline, women reported more bodily pain, poorer physical
and social functioning and leas vitality. However, despite comparable im-
provement on all scales, women continued to report poorer FH, even after
adjustment for differences in baseline characteristics. Conclusion: Men and
women receive similar benefit in FH from revascularization. Because women
present in pcerer FH, they remafn in poorer FH than men at one year post
procedure.
acale Men (291) Women (186)
Prior Post Prior Post
General Health 59.6t 63.0 56.2 57.5*
BodilyPain 51,0 73,5 45.s 66.9*
PhysicalFunoIlon 55.9 72.0 41.1 59.3*
Mental Hsalth 67.1 74.4 63.1 69.4’
Vimlhu 431 57.0 36.2 50.1”
928-16 TheImpactof RaatanosisonCornpariaonaof
Outcomeat OneYaarBetweenAngioplaatyand
BypaaaSurgaty
AS. Kurbaarr,T.J. Bowker, A.F. Rickards. Royal BronrptorIHospitaVNH&L/,
London, UK
PTCA is limit@ by restenosis. We assessed the impact of rsstenosis on one
year outcome rmmparieonsbetween angioplasty (PTCA)and bypass surgety
in the CABRI population.
Meffroc: In 514 patients who underwent PTCA in the CABRI trial, those
that clinically restenosad were identified. Clinical restenosis was defined as
initially successful PTCA followed by a second attempted revascularisation,
b@waan 10-200 days inclusive, either by PTCA at the initial site or by
bypass surgery, at or distal to the original site. Three groups were identified:
Bj’PSSSsurgery (CABG). pTCA with restenosis (RS) or without restenosis
(pT). Comparisons were: PT vs CABG, and PT vs RS. Outcomes assessad
were death, infarction, further ravasculartaations,and angina (CCS grades
1 or 21). Results: In the PTCA population RS = 12%. Death: no difference
between the three groups. Infarction: non-significantly worae in PT vs CABG
(Relative Risk 1.9, Confidence Interval 0.96-S.7, p = 0.064). No infarctions
in the RS group. Further revaacularisation: more common in PT vs CABG
(RR 8.6, Cl 5.14-14.41, p < 0.0C05). No further revascularisations in the RS
group. Angina: worse in PT vs CABG (RR 1.5, Cl 1.01-2.1, p < 0.05) and
also in RS VSPT (RR 2.0, Cl 1.2-3.3, p =0.006).
Conclusion: There remained a worae angina status and greater need for
repeat revascularisation in the PTCA group, deepite excluding those who
raatenoaad. Furthermore, in the PTCA population thosa who restanosad
when compared to those who did not, had a worse angina status, despite a
second ravascularisatiofl procedure.
D92817 CombinadAntiplateletPretreatmentwithAapirin
andTiclopidineReduceaIn-hoapitslCardiac
EventaFollowingElectiveCoronaryAngioplasty
J. vom Dahl, H.G. Klues, T. Reffelmann, F. Hendricks, P.Hanrath. University
Hospital, Aachen, Germany
In 1995, a total of 711 patienta (pts, 76°4 male, ~ + 9 years) with stable
angina pactoris symptoms were treatad electively by PTCA. Multiple vessel
dieaaaa was present in 56Y0,and reduced ventricular function (EF c 45%) in
S2%. PTCA was attempted for type B/C lesions (ACC/AHA classification) in
66°Y0and for restenoaes in 25%.
To shorten the intewal between a possible stent implantation and the
treatment effect of ticlopidine, all pta began antiplatelet therapy with 100 mg
aspirin and 2 x 250 mg ticlopidine ?1 day prior to angioplasty. During PTCA,
116 pta (group A, 16%) had stent implantation (95% Palmaz-Schatz), and
595 pts (group B) were treated by PTCA.only (incl. laser angioplasty and
rotational atheractomy). Stent implantation (1.4 +0.9 stentrdpt)was primarily
planned in 35%, for a Suboptimal PTCA result in 50%, and for a “bail-our
in 15%. Following PTCA, 21,000 NJhepattn/h were given for 24 hrs in both
groups. Pts in group A continued with the combined antiplatelet regimen for3
months followed by aspirin, group B received aspirin only. In-hospital eventa
were compared with 1993/4 (n = 1014, no significantly different patient or
lesion characteristics) without this pretreatment and with 2% stents.
Subacute stent thrombosis (SAT) in group A occured in 1/116 pta with no
SAT following discharge. Thus, combined antiplatelet pretreatment in com-
bination with a more frequent use of stents resulted in significantly reduced
PTCA related cardiac events without an increase of bleeding complication
during hospital stay.
1928-18( lncrea$$fnMeanPlateletVolumeasParameterfor
RestenoaiaFollowingSuccessfulPercutaneous
TransluminalCoronaryAngioplasty
L. Pizzulli, A. Yang, M. Zirbas, A. Hagendorff, B. Luderitz. Departrrrerrfof
Cardiolog~ UniversifyofBonn, Bonn, Germany
Since platelet size and activity correlate, the mean platelet volume (MPV)aaa
marker for platelet function was found to be increased in unstable angina and
myocardial infarction and is a risk factor for future coronary events in patienta
after myocardial infarction. The aim of our study was to assess, whether an
increased MPV 2-4 hours before PTCA influences the restenosis rate. We
studied 116 patients (pat) with either stable (n = 66) or unstable angina (n =
30) referred for single-vessel PTCA. All pat underwent repeat angiography
4-6 months after PTCA regardless of symptoms. Restenosis was defined as
a diameter SW’IOSiS Of> 50Y0 at angiographic fOllOW-Up.
Results:
In stable angina the MPV was significantly lower ea compared to pat with
unstable angina (6.1 + 0.4 fl vs. 6.7 + 0.5 fl; p < 0.01). Pat with restenosis
had a MPV which was significantly Iargercompared to pat with no restenoais
(p c 0.01). The pat with unstable angina who developed a reatenosis hadan
even larger MPV than any other pat subgroup and the restenosis rate in pat
with an MPV of >9 fl was 72%.
Rastenosis No-Rsstenosis
stable unstsble stsble unstable
MPV(rl) 5.5 l 0.4 5.9 * 0.5 8.0 * 0,4 8.3 & 0.7
Conclusion:. An increase in mean platelet volume is a riak factor and
predictor for restenosis following successful PTCA in stable and unstable
angina.
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[929-161 I Responseofthelnts~tLefWantricletohmreaesd
AfterloadDoesnotDependona Concomitant
Increasein’CoronaryPerfusionPreasure
M.K. Karunanithi, J.A. Young, W. Kalnins, M.P. Feneley. St. Vincent’s
Hospital, Sydne~ NSW, Australia
To determine the influence of the normal concomitant increase in corona~
perfusion pressure (CPP) with increased left ventricular (LV) afterload on
LV afterkrad sensitivity, 6 autonomically blocked open-chest dogs were in-
strumented with ultrasonic dimension transducers and micromanometera to
measure LV volume, LV pressure and CPP, respectively. The left main coro-
naty artery was perfused through a cannula with a side gate to the aortic
root. With the gate open, CPP increased in the normal manner with aortic
mnstriction (AC). With the gate closed, CPP waa maintained constant at
100 mmHg despite increased LVpressure with AC. Toquantifythe afterload-
response under each parfusion condition, the end-systolic pressure-volume
Group(n) Osath Ml CABG Re-PTCA Bleeding
A fllal nons 1.7% 2.6%# 0.6% 0.8%.., ...,
s (593) none 0.2% none 0.2% 0.8%
A+ B (711) nons 0.4% 0.4% 0.3% 0.8%
19S3/4 (1014) 0.6% 2.0%” 0.5”4 1.6%” 1%
*pc 0.05vs B, andvs A+ B; #3pts had uncomplicatedCA6G (no Ml) forintracomnsry
sient losswithstent rsmovalduringCABG.
Gate SW-EDV ESPV
slope hrtemspt Slope Intercspt
(erg ml-l 104) (ml) (mmHg ml-l (ml)
Control Open 7.9 i 4.1 18.0+ 13.7 3.8+ 3.0 –1.9 l 11.7
AC Open 7.2 + 5.0 11.3 +21.2 2,9+ 3.3
Control
–29.2&38.l
Closed 8.543.3 20,9 + 12.6 3.6* 2.3 –12.3+ 34.1
AC Closed 7.o + 2.9 fs,7i 9.0 1.6 kO.9 –48.3*2e.9
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(ESPV)andstrokework-and-diastolicvolume(SW-EDV)relationshipswere
determinedduringvena Osvalocclusionsperformedbefore(Control)and
duringAC.Resultsarepresentedasmean&SD (seeTable).
ACproduceda smalldownwardshiftof the SW-EDVrelationshipanda
muchlargerIeftwardshiftofthe ESPVrelationship(p -=0.0001),butthegate
positionexertedno influenceon theaeahiftain a multiplelinearregression
analyeia.Thus,the LVreaponseto increasedafterloeddoesnotdependon
thenormalconcomitantincreasein CPP.
1929-162[ LassrTranamyocardialRevaacutarization(LTMR)
ImproveaMyocardialBloodFlowViaCollatarala
O.Almanzs,P.Weeemer,C.A.Moreno,S. Revall,J.H.Sanchez,J.Ochsner,
J.P.Murgo,J. Cheirif.Oohsner Medicel Institutions, New Orleans, LA, USA
The inductionof collateralflow via LTMR-createdchannalshas beenthe
proposed,althoughunproven,mechanismof action behindthe apparent
symptomaticimprovementinpatientswithend-stageischemiccardiomyopa-
thy.InordertodetenminewhetherLTMRindeedcausessignificantincreaaes
in collateralbloodflow,we treated7 open-chestdogswith proximalLAD
atenoeeswithEclipseHolmiumLTMR.Radiolalx#edmicroaphereswerein-
jected at baseline and during total IAD occlusion (LADO). Following the
creation of the stenoaas and LTMR, the dogs were allowed to recover and
were restudied after 20 * 16 days. Microsphere injections were repeated
pra-LADO (ST), during LADO (IAD02), and during LADO + Dipyridamole
(0.56 mgkg, IV) infusion (lADO+DIP). Results are shown in the table below:
RaoionalBleed Flow [mUminf!a).
Baseline LADO ST LAD02 LADO+DIP
Mean 0.530 o.174a 0.578b o.450b t.261a,b,c
Std. Dev. 0.0s9 0.105 0.331 0.365 0.673
ap< 0.05 from Baseline; bp < 0.05 from LADO; Cp<0.01 from LAD02
Conclusion: LTMRinducessignificantincreasesin regional myocardial
blood flow to ieohemic areas via collaterals. Furthermore, these mllaterals
are developed enough to support recruitment of coronary reserve by Dipyri-
damole.
m929163 NG-monomethyl-l-arginine(1-NMMA)ImproveaLeftVentricularSyatolicFunctionLateAfter
CardiopulmonaryBypaaain NeonstalPiga
R. Chaturvedi, V. Hjortdal, E. Stenbog, H. Ravn, P.White, J. Pedereen,
T. Christensen, A. Block Thompeen, K. Sorensen, A. Redington. Royal
Brompton Hospital, London, UK, Aarfrus University Hospital, Aartrus,
Denmark
Animal studies suggest nitric oxide (NO) donore and I-arginine improve load-
depandent indices of LV function in the first 30 minutes peat-opb. However
theae indicea cannot separate cardiac from peripheral vaacular effects. In
addition only early LV function was evaluated, whereas the clinically signifi-
cant nadir in LV function occurs 9-12 hours pcat:bypaes (cpb) in neonates.
Eight neonatal piga (2 weeks age, mean weight 5 kg) had crystalloid cerdio-
plagic arrest, WI min crosaclamp, 60 min cpb, and received a dobutamine
infueion (2 @@rein) pra- and peat-cpb. At 12 hours peet-cpb the response
to a aingle i.v doae (7.5 mg, n =4) and cumulative doaea (7.5 mg, 37.5 mg,
75 mg, n = 4) of I-NMMA, waa assessed from real-time pressure-volume
100pausing mnduotance and microtip preesure catheters, with transient
WC snaring. Loaddependent (dddfm~, Wk., time Consfsnt of isovolu-
mic relexation[r]) and load-independent (end-systolicelastance, Ees) indices
were derived. Eea increased aignifioently (Friedman p -=0.05) with median
increases of I09Y0 (Dunnett p < 0.01) and 105% (p -=0.05) at 37.5 mg and
75 mg NMMA, respectively. Dp/dfmw tended to increase (median 13.2%)
but along with dpMtmi. (median 4.5%) and r (median 0.3%) did not reach
significance.
Cone/usion:Uaing load-independent indices, this isthefiretdemonstretion
that inhibition of NO syntheaia improves LV systolic function late post-opb.
[929-164[ ProlongedAdenosineExpoaureElicita
“AdrenergicStunning”hrNormalHeartaviaa
ProteinKinaeeC-DependentMechaniam
S.Pertini, E.P.Khoury, E.S. Chung, F. Bartl, R.A. Fenton, J.G. DobeonJr.,
T.E. Meyer. UniversrlyofMassachuaetta Medical Centec Worcestec MA,
USA
Adenoaine (Ado) axerte a multiplicity of cardiovaecuiar actions. While much
is known about the anti-lachemic (vaeodilator) actions of Ado, few data exist
about the chronic antiadrenergic actiona of this autcmid. To asaeee the
affect of prolonged expoaure to Ado on adrenergic responsiveness (AR)
in the normal heart, 16-wk-old rat hearts were isolated and perfused. AR
(+dP/dtmax) to 1O-a M iaoproterenol was determined before (C) and at W
min of 3.3 x 10-5 M (Ado) and 3.3 x 1O-eM Ado (Ado-low) or NaCi infusion,
and after 15,30 and 45 min of wash-out (V/O). Responseswere expreaaed se
a % of C. The same protocol was repeated following the concomitant infusion
of Ado and a) a selective AI antagonist, 6-cyclopantyl-l ,3-dipropylxanthine
(10-0 M, CPX), b) a protein kinase C (PKC) inhibitor, chelerythrine (2 x 1O-a
M, Chel), ore) Chel+ CPX.
“AdP/dt of C % dP/dtof C followingAdo WO
60 min infueiorr: 15 rein: 30 rein:
NeCl (n = 7)
45 rein:
95* 5 91 +6 96 d 6 96*4
Ado (;= 10) 31 k 6* 51 l4’ 61 +6* 74* 9*
Ado-low(n= 6) 67* 5“+ 73 k 5*t 77& 6*t 62 *6*
Ado+CPX (n = 10) 58 +6*t 78 i 7*t 6B i 9*t 69+ 10”
Ado+Chel (n = 13) 34 l3” 94 +5* 98+ 7+ 99* 7t
Ado+Chel+CPX (n = 6) 50 l4”+ 984 6t# 99+ 7~ 97+- 9#
Means * SEM; *p <0.05 vs NaCl; t p <0.05 vs Ado;#p <0.05 w Ado+CPX,
InterstitialAdo levels returned to baseline valuea within 5 minof WO. Sixty
min of Ado infuaion caused “adrenergic atunning” (AS) up to 45 min of Ado
WO. This Ado-induced lingering depression in AR was doae-depandent and
wee parlially abolished by a specific Al antagonist. PKC inhibition, alone or
in combination with the Al antagonist, prevented AS. Conclusion: Prolonged
Ado exposure elicita a long-lasting AS in normal hearts by PKCactivation via
AI- and non Al-receptor mediated pathwaya.
-] ParticipationofTGF-P, in Platelet-Mediated
CardioprotectionDuringMyocardial
lachemia-Reperfuaion
B. Yang, P.Mehta, B. Strstea, J.L. Mehta. University of Florida and VA
Medical Centec Gainesville, FL, USA
Plateletahavebeen shown toprotactmyocardium againat ischemia-reperfusion
injury in isolated rat hearts. We examined if the platelet-mediated cardiopro-
taction is related to release of transforming growth factor beta-1 (TGF-B1).
Isolated Sprague Dawley rat hearts were parfused with Krebs-Ringera buffer
and subjected to 25 min of ischemia followed by 30 min of reparfusion.
Ischemia-reperfusion in the buffer-perfused hearta (n = 13) resulted in a
marked increase in coronaty perfusion pressure and LVEDP,and decrease
in developed LV pressure (LVSP-LVEDP). Perfusion of hearts with autolo-
goua rat platelets (n = 10) attenuated (P < 0.01) these indicea of myooardial
dysfunction upon ischemia-reperfuaion. Similar cerdioproteotion was aeen
in hearta perfused with the supematants of ADP-aggregated platelets (n =
5). While coronary effluent from buffer alone-perfused hearta revealed no
immunoreactive (ir) TGF-BI, corona~ effluent from platelet-perfused hearts
revealed modest levels of irTGF-Bl (53 + 5 pg/ml), and coronary effluant
from aggregated platelet supernatant-parfused heatts revealed high Ievela
of irTGF-@l (392 + 12 pg/ml). Ischemia-reperfusion resulted in a marked
depletion of myocardial TGF-pI as determined by immunohiatochemistry.
Perfusionof hearts with platelets orsupematant of aggregated plateletacom-
pletely prevented the Ioasof myocerdial TGF-pI upon ischemia-reperfusion.
These obaenfations indicate that ischemia-reperfusion results in myooardial
dyafunotion aaaociated with a prompt decrease in myocardial TGF-PI, and
parfusion of hearts with platelets or supernatant of aggregated platelets at-
tenuates myocardial dyafunofion and preserves myooardial TGF-fll during
by ischemia-reparfusion. Weauggest that platelet TGF-BI participates in the
cerdioprotective effect of platelets against ischemia reparfuaion-mediated
myocardial injury.
1929-1681 EffectaofCriticalCoronaryStenoaiaon Systolic
LVFunctionQuantifiedby Preasure+folume
RelationaDuringDobutamine
P.$teendijk, J. Baan, Jr., E.T.Van Der Velde, J. Baan Leiden. University
Hospital, Dept Cardiology The Netherlands
A coronary stenosis (STEN) may be tolerated at rest, but ceuae iachemia
during exercise. We examined whether preaaure-volume (PV) relations may
be used to reveal the presence of the STEN at rest and to quantify the
effecls of STEN during dobutamine (DOB) stress. Methods: Studiee were
performed in 14dogs. LVvolume(V) weemeaaured byconductanceoetheter,
LV pressure (P) by microtip catheter, LCX flow by Doppler probe. The STEN
was induced by a partial LCX occlusion. Measurements in control(CON)
and with STENwere performedat reat and at 5 levelsof DOB (2.5-20
#g/kg/rein).The followingPV relationswere derivedfrom date acquired
duringgradualprelosdreduction:ESPVR(End-SyatolicPV Relation), dPdt
(dP/dt-mex vs EDV) and PRSW (Stroke Work vs EDV). We assessed both
